Comprehensive medication guide to Methocarbamol including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$15 copay for generic Methocarbamol on most commercial plans (Tier 1–2 preferred generic); approximately 70% of Medicare Part D plans cover it at $0–$8 per fill.
Estimated Cash Pricing
$27–$29 retail cash price for 30 tablets (500 mg); as low as $5–$6 with GoodRx or SingleCare coupons for a 30-day supply.
Medfinder Findability Score
68/100
Summarize with AI
On this page
Methocarbamol is a centrally-acting skeletal muscle relaxant that has been FDA-approved since July 16, 1957. It is most commonly known by its former brand name Robaxin (the brand was discontinued by Endo Pharmaceuticals in January 2020, though generic Methocarbamol remains widely available). In 2023, Methocarbamol was the 121st most commonly prescribed medication in the United States, with more than 5 million prescriptions filled annually.
Methocarbamol is FDA-approved as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. This includes common conditions such as back pain, neck pain, muscle strains, sprains, and sports injuries. The injectable form is also used in the treatment of tetanus.
Compared to other muscle relaxants like cyclobenzaprine, Methocarbamol tends to cause less sedation and lacks the anticholinergic side effects (dry mouth, constipation, heart rhythm changes) associated with drugs structurally similar to tricyclic antidepressants. It is not a controlled substance and can be prescribed via telehealth.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Despite being called a "muscle relaxant," Methocarbamol does not directly act on muscle fibers. The FDA label states that its mechanism of action "has not been established" but may be due to general central nervous system (CNS) depression. It has no direct action on the motor end plate or peripheral nerve fibers.
The most widely accepted theory is that Methocarbamol suppresses polysynaptic spinal reflexes — the neural circuits that amplify and sustain involuntary muscle contractions. By damping these reflex pathways in the spinal cord, it reduces the neural signals that drive muscle spasm and associated pain.
Methocarbamol begins working approximately 30 minutes after an oral dose. It has a short half-life of 1–2 hours in healthy adults, meaning it is metabolized relatively quickly. It is metabolized via dealkylation and hydroxylation, with metabolites excreted in urine. Patients with liver cirrhosis experience reduced clearance (half-life extends to approximately 3.4 hours), and dose monitoring is warranted in hepatic impairment.
500 mg — tablet
Oral tablet; initial dosing 1500 mg QID for 48-72 hours, then reduce to 750 mg QID or 1500 mg TID for maintenance
750 mg — tablet
Oral tablet; initial dosing 1500 mg QID for 48-72 hours (2 tablets), then reduce to maintenance dosing
100 mg/mL — injectable solution
For IV or IM use in hospital/clinic only; not for home use; contraindicated in renal impairment
Methocarbamol is not currently listed as a formal national drug shortage by the FDA. However, its availability at individual pharmacies can be inconsistent. The market has contracted significantly over the past decade — Par Pharmaceuticals (2018), Virtus (2019), and the Robaxin brand manufacturer Endo (2020) all discontinued their products. The current active suppliers are Bayshore, Camber, and Granules Pharmaceuticals, which collectively serve approximately 5 million annual prescriptions.
This supplier consolidation means localized pharmacy-level shortages can occur, particularly at large chain pharmacies that rely on centralized distribution. Independent pharmacies with different distributor relationships often have stock when chains do not. Both the 500 mg and 750 mg tablet strengths are available, though availability may vary by strength at any given pharmacy.
If your pharmacy is out of Methocarbamol, use medfinder to check which pharmacies near you have it in stock. medfinder contacts local pharmacies on your behalf and texts you the results — no hold music, no wasted trips.
Because Methocarbamol is not a DEA-scheduled controlled substance, it can be prescribed by any licensed prescriber. There are no special DEA registration requirements or prescribing restrictions beyond a standard prescription. This makes it broadly accessible through primary care, urgent care, telehealth, and specialty settings.
Primary Care Physicians (PCPs, family medicine, internal medicine)
Emergency Medicine Physicians
Orthopedic Surgeons and Sports Medicine Physicians
Physiatrists (Physical Medicine and Rehabilitation)
Neurologists
Nurse Practitioners (NPs) and Physician Assistants (PAs)
Methocarbamol is also available via telehealth in all U.S. states. Because it is not a controlled substance, telehealth providers can prescribe it without the additional DEA requirements that apply to Schedule II-IV drugs. Popular telehealth platforms such as Teladoc, MDLive, PlushCare, and Sesame can prescribe Methocarbamol during a same-day virtual visit.
No. Methocarbamol is not a DEA-scheduled controlled substance. This is an important distinction compared to some other muscle relaxants — for example, carisoprodol (Soma) is DEA Schedule IV due to its recognized abuse potential. Methocarbamol carries no federal scheduling.
Because it is not controlled, Methocarbamol can be prescribed by any licensed healthcare provider (including NPs and PAs) and can be prescribed via telehealth visits in all states without the additional DEA requirements that apply to controlled substances. Prescriptions can also be transferred between pharmacies without special restrictions. Research on Methocarbamol's abuse potential has produced mixed results — some studies show modest abuse-like effects at high doses — but the product label does not carry a formal addiction or dependence warning.
Drowsiness / sedation (most common)
Dizziness or lightheadedness
Headache
Nausea and upset stomach
Metallic taste in the mouth
Blurred vision or double vision (diplopia)
Confusion or memory difficulties (more common in elderly)
Nasal congestion
Anaphylaxis / severe allergic reaction (hives, swelling, difficulty breathing)
Seizures (rare; higher risk with IV administration in epilepsy patients)
Fainting / syncope
Severe CNS depression (especially when combined with opioids, benzodiazepines, or alcohol)
Cholestatic jaundice (rare)
Leukopenia (rare)
Know what you need? Skip the search.
Cyclobenzaprine (Flexeril)
Most commonly prescribed muscle relaxant; similar antispasmodic use; more sedating and more drug interactions (anticholinergic effects, cardiac contraindications); available as generic
Tizanidine (Zanaflex)
Alpha-2 agonist; short-acting; useful for both spasm and spasticity; requires liver monitoring; significant drug interactions (avoid with ciprofloxacin/fluvoxamine)
Baclofen (Lioresal)
GABA-B agonist; best for neurological spasticity (MS, SCI); must be tapered; abrupt discontinuation causes withdrawal
Metaxalone (Skelaxin)
Least sedating muscle relaxant; requires liver monitoring; significantly higher cost than generic methocarbamol
Prefer Methocarbamol? We can find it.
Alcohol
majorAdditive CNS depression; significantly amplifies sedation; overdose deaths reported with combination; absolute contraindication
Opioids (oxycodone, hydrocodone, morphine, tramadol)
majorProfound sedation, respiratory depression, coma, and death risk; use only when clinical benefit clearly outweighs risk with close monitoring
Benzodiazepines (diazepam, alprazolam, lorazepam)
majorAdditive CNS-depressant effects; increased sedation, respiratory depression, and fall risk
Pyridostigmine
moderateMethocarbamol may inhibit the effect of pyridostigmine; use with caution in myasthenia gravis patients
Sedating antihistamines (diphenhydramine)
moderateAdditive CNS sedation; avoid OTC sleep aids and antihistamines while taking methocarbamol
Other muscle relaxants
majorStacking CNS depressants; rarely clinically appropriate; significantly increased oversedation and respiratory depression risk
Methocarbamol is one of the oldest and most established muscle relaxants available, with nearly 70 years of clinical use since its 1957 FDA approval. It remains a practical first-line option for short-term acute musculoskeletal pain — affordable, not controlled, less sedating than some alternatives, and available via telehealth. With more than 5 million annual prescriptions, it is firmly embedded in routine clinical practice.
The main challenge with Methocarbamol in 2026 is not cost or safety — it's availability. Supplier consolidation over the past several years means the drug is sometimes harder to find at local pharmacies than its widespread use would suggest. Patients may need to try multiple pharmacies or ask for a special order. Independent pharmacies are often the best bet when major chain pharmacies are out of stock.
If you're having difficulty finding Methocarbamol at your pharmacy, medfinder can help. You provide your medication and ZIP code, and medfinder contacts pharmacies near you to find which ones have it in stock. Results are sent directly to your phone — no hold music, no wasted trips to pharmacies that don't have it.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards